EuroBioForum 2013 - Day 2 | Alberto Baldi

/ 1 Bioindustry Park 2013– All Rights Reserved


Alberto Baldi

[email protected]

Munich, May 28th, 2013

bioPmed, a step beyond personalised medicine


Piemonte cluster and Bioindustry Park Silvano Fumero

Key trends bioPmed cluster initiative

bioPmed strategic approach

Concept scale-up

Take away messages and offer

CONTENTS


Torino

Verbania

Biella Novara

Vercelli

Alessandria

Cuneo

Asti

4.4 million inhabitants

€ 123.4 billion GDP

€ 38.5 billion export

467,500 companies

€ 2.2 billion R&D investments

1,000 R&D contracts

220 R&D centers, 380 Labs

6 Science & Technology Parks

4 Universities

Strong relationships with

other European Regions

1st region in Italy for:

Private R&D investment

Hi-tech patents

ITALY: PIEMONTE REGION


Science Park focused on life sciences, created with the support of

Regione Piemonte in the EU programs framework (beginning 90’s) -

Operational since 1998.

It hosts more than 30 organizations

Managing company of the Innovation Cluster bioPmed

Member of national and international networks

22.000 sqm labs, office spaces

R&D shared facilities

R&D scientific services (Able

Biosciences initiatives)

1 incubator

Consultancy in biomanagement

Conference centre

www.bioindustrypark.eu

Offer

BIOINDUSTRY PARK SILVANO FUMERO


KEY TRENDS

• Health care is a priority for all actors of the value chain – Societal needs

– Cost pressure

– Lead markets (e.g. Ageing, metabolic diseases, cancer, CNS, etc)

– Political priority (Horizon 2020)

• The paradigm for health care is changing – From a “pill for all” to a personalised approach

– From an acute problem to a managed problem

– From local development to global value creation networks

– From a “mono-technoligical” approach to a converging technologies approach (Es. diagnostic + therapies + devices altogether)

• The health care sector has now a global, multi-technological and trans-market dimension, touching also different “traditional” sectors, from agro-food to ICT.


A EU “world class cluster” dedicated to bio and medical technologies –

created in 2009

A core founder of the ALISEI (Advanced LIfe SciEnces in Italy) national

cluster that involves 13 different regional actors

80+ CORE

MEMBERS

370+ ENLARGE

COMMUNITY

National &

International Hubs

The bioPmed

Community

A shared smart approach for

innovation:

converging technologies

BIOPMED CLUSTER INITIATIVE

“Overlapping different

technological knowledge

to reach innovative

solutions to ensure a better future”

Synergies with local

clusters (ICT, New

materials,

textiles...), with EP

and non EP clusters

∼200 health care

132 R&D centers

3924 scientists

Companies, Universities,

R&D centers, foundations


Project building Working groups

Community building

Shared access to

infrastructures (material / immaterial)

R&D Projects Added

value shared services

International networking International clusters

Governance – Labeling

Regional financing

Events organisation and participation, information, opportunities and support to single companies, universities

and agencies in sectorial internationalisation

Council of European Bioregions

International projects International agreements Soft landing agreements

SMEs INTERNATIONALISATION AND

THE CLUSTER ENVIRONMENT: BIOPMED APPROACH


bioPMed obtained the “Bronze Label”

from the European Secretariat for Cluster

Analysis”

bioPmed ranked 1st in a national

performance evaluation of clusters and

science parks Source: “Dai distretti industriali ai poli di innovazione.

L'Italia nel Mediterraneo, M. Ferarra, R. Mavilia EGEA, 2012”

Companies contacted and involved 330

Scientist contacted and involved 3500

Organizations formally and

contractually linked 82

Total output project building

activities 143

Technical work-shops organized 34

Companies involved in

internationalisation and international

activities

147

Advanced services financed 15

Feasibility studies and R&D

projects financed 29

EU funded project ongoing and

presented 10

% of members involved in projects

(cumulative) 100%

Overall value of initiatives linked to

cluster activities 20.860.231

Involvement in institutional advisory

board external to the region 4

BIOPMED: PERFORMANCES


Ge

no

mic

s,

Bio

che

mis

try,

M

ole

cula

r

& c

ellu

lar

bio

logy

D

iagn

ost

ic

& T

he

ran

ost

ics

Ele

ctro

nic

al, m

ed

ical

&

lab

ora

tory

e

qu

ipm

en

t M

ed

ical

bio

mat

eri

als

Me

dic

al t

ech

no

logy

&

Bio

me

dic

al

en

gin

ee

rin

g Fu

nct

ion

al f

oo

d

Mic

rob

iolo

gica

l co

nso

rtia

C

om

pu

ter

scie

nce

s

Disease Prevention ROTARIC ATHIMAG SAFE TAN SUN TAN

PREVI

IaRO ROTARIC

Nutratec

MicoDiaBreast

ARAS BACOSTE

Prothesis, biomedical

Devices/instrumentation

& drug delivery

BIOBONE CARDIOMITRAL

SWAP

SiNplant Self exp. DES TINET; I.B.G.

IPEEI BONEJECT

KEME PIEDMONT

BIOMAG ANTIBACOSS

Dense-gas CRYO CRYOPHARMA

NANOSTENT FIDIS

BIOMICROFAB DESTINI

WILOP; JIGTO FACE; ORECO

BIOMAG

NeuroVirtual3D Nuvola3D

RICCAmente

Regenerative Medicine

MOSQUITO HYPERSPECTRA

STELLA

BICONerve TINET; I.B.G.

QUANTADIPO BONEJECT PIEDMONT

ANTIBACOSS

PLA scaffolds NanoStem

B.B.S. FACE

WEB BI

Pharmaceutical

TAB2 NOVADEP

TLR7A ERP

NATIMAB ATHEROVAX

PSSEIK

Personalized Molecular Medicine

MOSQUITO GNRs

Pred_HEALTH FaPre

P-MOSP

Diagnostic EPIgenetic screening

NuGeSa

FAST

Beta-agonist detection DMS; Bioprotech

ATHIMAG HYPERSPECTRA; STELLA

LOCHTECH MicroDiBi

PROMOTECO BANP.

TrCD; Idata E_LAB; FAST

P-MOSP

Veterinary FLUOMAG CANESTRO

)

Specialisation fields have

been derived from company

based projects


EAPB

Biobay,

Scientific

Park

FABA

Federation of

Asian Biotech

Associations

CBS

FR: Lyonbiopole; ADEBAG; Eurobiomed; Genopole;

I-Care

DE: BioM; Technologiepark Heidelberg, bioTop

PL: Wrocław Center for S&T in Medicine

ES: BioCAT; Parque Tecnologico di Vizkaia

IT: Toscana Life Sciences

CH: BioAlps ; DK: MVA

UK: One Nucleus; SWE:

Stockolm Science City

Technology

Centre of New

Jersey

Israel

BioNegev cluster;

RAD biomed

BioCulture

FIPASE

eLSi

BIOPMED: INTERNATIONAL NETWORK AND PROJECTS


The “traditional approach”

(One problem, one technology, one solution)

The “bioPmed smart approach”

(Converging technologies)

- Up to 250 companies working specifically in

health care

- Over xx.000 companies working in ICT,

Mechatronics, New Materials, textiles, etc

80+ bioPmed cluster CORE MEMBERS

share the approach of a smart Healthcare cluster aiming at

“Overlapping different technological knowledge to reach innovative solutions to

unmet medical needs and ensure a better future”

THE BIOPMED SMART APPROACH


BIOENGINEERING

BIOLOGY ENGINEERING

COMPUTER SCIENCE

NANOTECHNOLOGY

BIOLOGY

ENGINEERING

CHEMISTRY

PHYSICS

COMPUTER SCIENCE

BIO MECHATRONICS

MECHANICAL ENGINEERING

ELECTRICAL ENGINEERING

COMPUTER SCIENCE

PERVASIVE COMPUTING

This includes engineering, computer science and all of the

liberal arts

MATERIAL SCIENCE

MATERIAL ENGINEERIN

G

CHEMISTRY

PHYSICS

* Source: Proceedings of the 2002 American Society for Engineering Education Annual Conference & Exposition Copyright 2002, American Society for Engineering Education

BIOLOGY

BASED ON CONVERGING TECHNOLOGIES


AND A STRATEGIC PERSPECTIVE

• While the current, almost “traditional”, concept of Personalised

Medicine stands for the customisation of healthcare for patient

subgroups through medical decisions, practices and products,

the future will be probably the development of a Personalised

Healthcare with a solution-driven approach, bringing together

the necessary industry sectors.

• This shall not only involve therapeutics and diagnostics research

& development, but also include other technological

approaches for the lifelong management of health and

healthcare, like e-Health (patient care using IT solutions and

devices), medical technologies, new materials, electronics and

mechatronics, but also the involvement of “traditional” low-

medium tech sectors such as agro-food, cosmetics and textiles.


WORKING ON LINKS BETWEEN DIFFERENT TECHNOLOGICAL & MARKET FIELDS

Therapy

Diagnostic

Med-tech

Cosmetic

Health systems

Food

Personalised medicine

Personalised health care approach

Key Enabling Technologies (KET) and Future Emerging Technologies (FET)

R&D, Industry, PAs, Users

T

e

c

h

n

o

l

o

g

i

e

s


To develop a common and joint internationalisation strategy for the

4 Life Sciences Clusters, in order to reinforce the European SMEs’

competitiveness outside Europe

Mutualising and sharing internationalisation tools (programs,

practices, networks) already implemented to obtain economy of

scale/knowledge

Identifying the most efficient tools for SMEs’ competitiveness on the

global market

Testing common pilot actions towards 3 targeted markets: Brazil,

China, United States

Reinforcing the visibility of the 4 European Life Sciences Clusters

together and European competences worldwide

ERAI (Rhône-Alpes, FR) Project Leader

Lyonbiopole (Rhône-Alpes, FR) Host Cluster

BioCat (Catalonia, SP) Invited Cluster

BioM (Bayern Region, DE) Invited Cluster

BioPmed (Piedmont, IT) Invited Cluster

www.bioxcluster.com

AN INTERNATIONAL PLATFORM BASED ON A SHARED VISION


A POSSIBLE FURTHER STEP: A STRATEGIC CLUSTER PARTNERSHIP FOR PERSONALIZED MEDICINE

bioXclusters as the common starting platform to involve other European health clusters to develop a strong

European Alliance on Personalised Healthcare

The Strategic Cluster Partnership (ESCP) initiative with a focus on Personalised Healthcare

5 different market-oriented clusters (bioPmed, Lyonbiopole, BioM, BioCat and Health Science Scotland, 3 with quality assessed ESCA Bronze label, 4 involved in a world class cluster project, bioXclusters)

A common strategic agenda based on an intersectorial converging technologies approach

First step of evaluation already passed

A global vision: Today US China Brazil

and in the future… Korea Japan North Africa


The health care paradigm is changing:

Cost factor

Technology advancements

Societal needs

bioPmed is leveraging on all available technologies in order to

develop - through R&D projects - solutions to such challenges

bioPmed is using the power of partnership to work together

with key clusters in Europe to create a pan European platform -

based on a personalised healthcare vision - that could act as a

real global actor.

TAKE AWAY MESSAGES


Try to think big and on the long term

Life Long health management should be

the paradigm

Work on the integration of healthcare

systems at European Level

TOP 3 RECOMMENDATIONS FOR ACHIEVING TANGIBLE RESULTS


A solution-oriented approach, based on the

integration of multiple technological

domains

An international vision and development

strategy based on partnerships and

complementarities

WHAT CAN WE OFFER


Partners sharing our vision and approach

Ready to work on a global scale

WHAT ARE WE LOOKING FOR


BIO-Europe Spring®

will be organised

in Turin (Piemonte)

March 10–12, 2014

http://www.ebdgroup.com/bes/program/index.php

BIO-EUROPE SPRING® 2014

Bioindustry Park Silvano Fumero S.p.A.

Alberto Baldi DBusiness Development and International projects [email protected] Via Ribes, 5 10010 Colleretto Giacosa (TO) ITALY Tel. +39-0125-561311 [email protected] www.biopmed.eu www.bioindustrypark.eu

It is the team that wins

not the single player…..

mailto:[email protected]

mailto:[email protected]

http://www.biopmed.eu

http://www.biopmed.eu

http://www.bioindustrypark.eu

Health & Medicine

EuroBioForum 2013 - Day 2 | Alberto Baldi